1. Home
  2. CRDO vs TAK Comparison

CRDO vs TAK Comparison

Compare CRDO & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Credo Technology Group Holding Ltd

CRDO

Credo Technology Group Holding Ltd

HOLD

Current Price

$218.67

Market Cap

50.7B

Sector

Technology

ML Signal

HOLD

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

HOLD

Current Price

$16.87

Market Cap

55.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRDO
TAK
Founded
2008
1781
Country
Cayman Islands
Japan
Employees
N/A
47029
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.7B
55.1B
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
CRDO
TAK
Price
$218.67
$16.87
Analyst Decision
Strong Buy
Analyst Count
14
0
Target Price
$179.62
N/A
AVG Volume (30 Days)
5.7M
3.7M
Earning Date
06-01-2026
05-13-2026
Dividend Yield
N/A
3.24%
EPS Growth
765.52
N/A
EPS
2.51
N/A
Revenue
$1,335,116,000.00
N/A
Revenue This Year
$210.92
$0.16
Revenue Next Year
$57.22
$1.22
P/E Ratio
$82.47
$41.25
Revenue Growth
205.68
N/A
52 Week Low
$86.49
$12.99
52 Week High
$308.67
$18.90

Technical Indicators

Market Signals
Indicator
CRDO
TAK
Relative Strength Index (RSI) 47.01 50.92
Support Level $192.93 $16.21
Resistance Level $241.14 $17.02
Average True Range (ATR) 17.84 0.28
MACD -2.07 -0.02
Stochastic Oscillator 54.46 39.17

Price Performance

Historical Comparison
CRDO
TAK

About CRDO Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd provides connectivity solutions for AI-driven applications, cloud computing, and hyperscale networks. Its high-speed copper and optical interconnect products support data infrastructure demands. The Company's product portfolio includes ZeroFlap (ZF) Active Electrical Cables (AECs), ZF optical transceivers, OmniConnect memory solutions, and retimers and DSPs for optical and copper Ethernet and PCIe, leveraging the PILOT diagnostic and analytics software platform. Its products are based on Serializer/Deserializer (SerDes) and Digital Signal Processor (DSP) technologies and include integrated circuits (ICs), Active Electrical Cables (AECs), SerDes Chiplets, and SerDes IP licensing solutions. The United States generates the maximum revenue.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.

Share on Social Networks: